HPN in Advanced Cancer Flashcards
How might multmodal treatment look?
Multiple Care Providers and a journey spanning months
* Chemotherapy
* Radiation therapy
* Surgery
* Multimodal therapy: CT/RT; Surgery/CRT; CRT/Surgery/Palliation
What is typically the adequacy of energy and protein via oral route?
- energy: 77%
- protein: 69%
What are strong reccomendations from the ESPEN guidelines?
- Screening
- Assessment: to include objective markers, nutrition impact symptoms, function, body comp
- Nutrient Provision: Energy: 25-30kcal/kg, Protein: 1-1.5 gm/kg, Vitamins: RDA (not Excess esp. vit E)
- Refeeding Syndrome
Efficacy of nutrition intervention from ESPEN
- Use Supplements if needed
- avoid harmful diets
- EN or PN if oral intake is insufficient
- Pursue ERAS strategies which are specific approach to surgery to to avoid fasting and initiate feeding soon after
ESPEN nutrition in advanced cancer
- Assessment indicated
- Consider EN or PN if therapy has the potential to impact survival and Quality of Life
ESPEN definition of intestinal failure
the reduction of gut function below the minimum necessary for the absorption of macronutrients and/or water and electrolytes, such that intravenous supplementation is required to maintain health and/or growth.
intestinal insufficiency
reduction of gut absorptive function that doesn’t require intravenous supplementation to maintain health and/or growth
ESPEN classification of intestinal failure in adults
Intestinal failure can be classified into five major pathophysiological conditions, which may originate from various gastrointestinal or systemic diseases:
1. short bowel
2. intestinal fistula
3. intestinal dysmotility (snipped vagus nerve)
4. mechanical obstruction
5. extensive small bowel mucosal disease
What is indicated by this graph?
HPN has gotten a lot safer
Survival and PN Dependence in Adults With SBS/IF
After 2 yrs probability of permanent intestinal failure is 94%
* Survival (2, 5 yrs): 86%, 75%
* PN Dependence (2, 5 yrs): 49%, 45%
* Basically dont really get off of PN
Mortality of intestinal failure
Death is related to:
* underlying disease
* TPN related liver disease (15% long term TPN)
* Sepsis (catheter related), related to residual bowel length
* malnutrition
Use of HPN in advanced cancer care
Addresses the malnutrition associated with IF
* reduction in food intake
* Metabolic Derangement: Insulin resistance, lipolysis
* Systemic Inflammation driving catabolism
* Muscle Protein Depletion – results in reduction in quality of life, treatment intolerance, reduction in physical function
Ethical considerations in feeding patients with advanced cancer
- Respect for the religious, cultural and ethnic background of patients
- Consideration of social, emotional and existential aspects
- The risks and detriments as well as the possible futility of artificial nutrition must be weighed against possible physiologic and or psychological benefits, for a given patient and family.
- As a general rule, the risks of PN are regarded to outweigh its benefits for patients with a prognosis of less than 2 months. However, in some cultures, active feeding in any form is regarded as essential.
- Withdrawal of artificial feeding or deciding not to initiate artificial feeding in a patient who is unable to consume food is usually considered only in an end-of-life setting.
- Potential Benefits: Survival, QOL
What outcomes does HPN impact?
- mortality
- survival
- QoL
Prognosis of incurable cachectic cancer patients on HPN